Essen, June 10, 2016
Essen, Germany. Evonik Nutrition & Care GmbH will implement price increases for its Antiseptic and desinfactant ingredient Chlorhexidine Digluconate. This price adjustment is necessary to maintain the high level of quality and regulatory requirements Evonik customers are accustomed to.
Evonik is committed to investments that enhance the quality and support the regulatory requirements which enables its customers’ a reliable and sustainable growth.
About Nutrition & Care
The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,000 employees in 2015.
About Evonik
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the Nutrition & Care, Resource Efficiency and Performance Materials segments. The company benefits from its innovative prowess and integrated technology platforms. In 2015 more than 33,000 employees were employed at Evonik.
Disclaimer
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.
